ITC Must Consider Amgen, Roche Dispute Over Mircera
A federal appeals court has affirmed a ruling allowing Roche Holding AG to import its anemia drug Mircera into the U.S. as long as the company doesn't sell it. But the...To view the full article, register now.
Already a subscriber? Click here to view full article